Virtual Practice

Dr. Keith Stockerl-Goldstein

Internal Medicine - Hematology & Oncology
Saint Louis, MO
About me
I specialize in
Internal Medicine - Hematology & Oncology
I have been in practice
29 years
I am licensed to see patients from
I speak
I'm known for
Recommend me
My answers and insights have
Saved 6 lives
Helped 1,367,333 people
Received 3,640 doctor agrees
Received 852 thanks
Here are kind words from others
excellent answers. Dr Keith truly understands his field of expertise
Recommend me
I am located at
660 S. Euclid Ave
CB 8007
Saint Louis , MO 63110
Office hours
Mon 9:00am - 5:00pm
Tue 9:00am - 5:00pm
Wed 9:00am - 5:00pm
Thu 9:00am - 5:00pm
Fri 9:00am - 5:00pm
I was educated and trained at
Medical / Graduate School
UCLA School of Medicine, CA
Academic Appointments
Associate Professor of Medicine, Washington University School of Medicine
I've won the following awards
Top Oncologist and Hematologist, Missouri
Fall 2017
Top Oncologist and Hematologist, Missouri
Spring 2017
Top Oncologist and Hematologist, Missouri
Spring 2017
I've published
Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.
Journal of the National Comprehensive Cancer Network : JNCCN, 10, 1211-9 (2012)
K C Anderson, M Alsina, W Bensinger, J S Biermann, A D Cohen, S Devine, B Djulbegovic, E A Faber, C Gasparetto, F Hernandez-Ilizaliturri, C A Huff, A Kassim, A Y Krishnan, B C Medeiros, R Meredith, N Raje, J Schriber, S Singhal, G Somlo, K Stockerl-Goldstein, S P Treon, G Tricot, D M Weber, J Yahalom, F Yunus, R Kumar, D A Shead
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma.
Blood, 120, 1801-9 (2012)
A J Jakubowiak, D Dytfeld, K A Griffith, D Lebovic, D H Vesole, S Jagannath, A Al-Zoubi, T Anderson, B Nordgren, K Detweiler-Short, K Stockerl-Goldstein, A Ahmed, T Jobkar, D E Durecki, K McDonnell, M Mietzel, D Couriel, M Kaminski, R Vij
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia.
Blood, 119, 3917-24 (2012)
G L Uy, M P Rettig, I H Motabi, K McFarland, K M Trinkaus, L M Hladnik, S Kulkarni, C N Abboud, A F Cashen, K E Stockerl-Goldstein, R Vij, P Westervelt, J F DiPersio